Optimus Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is RIVAROXABAN, with a corresponding US DMF Number 32846.
Remarkably, this DMF maintains an Active status since its submission on February 22, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 01, 2019, and payment made on March 06, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II